• IANS
• 15 Mar, 2021

New Delhi: A Mumbai-based bio-pharmaceutical firm has received approval from India's drug regulatory authority to use an anti-fungal drug for the treatment of black fungus or Mucormycosis, which recently saw an uprise among the patients recovering from the Covid-19.The firm, Bharat Serums and Vaccines Limited, has become the first company in India to receive the approval from Drug Controller General of India (DCGI) to use anti-fungal medication -- Liposomal Amphotericin B or LAmB
Read more...